Yanhong Chu

557 total citations
28 papers, 440 citations indexed

About

Yanhong Chu is a scholar working on Oncology, Immunology and Parasitology. According to data from OpenAlex, Yanhong Chu has authored 28 papers receiving a total of 440 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 9 papers in Immunology and 7 papers in Parasitology. Recurrent topics in Yanhong Chu's work include Immunotherapy and Immune Responses (9 papers), Cancer Immunotherapy and Biomarkers (8 papers) and CAR-T cell therapy research (5 papers). Yanhong Chu is often cited by papers focused on Immunotherapy and Immune Responses (9 papers), Cancer Immunotherapy and Biomarkers (8 papers) and CAR-T cell therapy research (5 papers). Yanhong Chu collaborates with scholars based in China, Hong Kong and United States. Yanhong Chu's co-authors include Baorui Liu, Qin Liu, Jia Wei, Qin Liu, Lixia Yu, Jie Shao, Yaohua Ke, Rutian Li, Qiuping Xu and Hanqing Qian and has published in prestigious journals such as Advanced Functional Materials, Scientific Reports and Advanced Science.

In The Last Decade

Yanhong Chu

26 papers receiving 436 citations

Peers

Yanhong Chu
Yanhong Chu
Citations per year, relative to Yanhong Chu Yanhong Chu (= 1×) peers Nastaran Barati

Countries citing papers authored by Yanhong Chu

Since Specialization
Citations

This map shows the geographic impact of Yanhong Chu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yanhong Chu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yanhong Chu more than expected).

Fields of papers citing papers by Yanhong Chu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yanhong Chu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yanhong Chu. The network helps show where Yanhong Chu may publish in the future.

Co-authorship network of co-authors of Yanhong Chu

This figure shows the co-authorship network connecting the top 25 collaborators of Yanhong Chu. A scholar is included among the top collaborators of Yanhong Chu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yanhong Chu. Yanhong Chu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Feng, Xiaoyu, Hao Zhu, Yan Wang, et al.. (2025). Improved Hypoxic Microenvironment By Nanoformulation For Effective T Cell Therapy In Mice Model. International Journal of Nanomedicine. Volume 20. 10073–10087.
2.
Chu, Yanhong, Lifeng Wang, Yaohua Ke, et al.. (2024). A multifunctional mesoporous silica drug delivery nanosystem that ameliorates tumor hypoxia and increases radiotherapy efficacy. NPG Asia Materials. 16(1). 5 indexed citations
3.
Ke, Yaohua, Kai Xin, Yaping Tao, et al.. (2024). A Thermosensitive Bi‐Adjuvant Hydrogel Triggers Epitope Spreading to Promote the Anti‐Tumor Efficacy of Frameshift Neoantigens. Advanced Science. 11(14). e2306889–e2306889. 10 indexed citations
4.
Wang, Xinyue, Fanyan Meng, Xiang Li, et al.. (2023). Nanomodified Switch Induced Precise and Moderate Activation of CAR‐T Cells for Solid Tumors. Advanced Science. 10(12). e2205044–e2205044. 14 indexed citations
5.
Wang, Xinyue, Xiang Li, Lin Li, et al.. (2023). Nanomodified Switch Induced Precise and Moderate Activation of CAR‐T Cells for Solid Tumors (Adv. Sci. 12/2023). Advanced Science. 10(12). 1 indexed citations
6.
Chu, Yanhong, Jie Xiao, Yueling Yang, et al.. (2023). Enhanced systemic tumor suppression by in situ vaccine combining radiation and OX40 agonist with CpG therapy. Journal of Translational Medicine. 21(1). 619–619. 7 indexed citations
7.
Bei, Yuncheng, Yanhong Chu, Zhichen Sun, et al.. (2023). Membrane fusogenic nanoparticle‐based HLA‐peptide‐addressing universal T cell receptor‐engineered T (HAUL TCR‐T) cell therapy in solid tumor. Bioengineering & Translational Medicine. 8(6). e10585–e10585. 6 indexed citations
8.
Chu, Yanhong, Yaohua Ke, Xiaoyu Feng, et al.. (2022). Lymph node-targeted neoantigen nanovaccines potentiate anti-tumor immune responses of post-surgical melanoma. Journal of Nanobiotechnology. 20(1). 190–190. 40 indexed citations
9.
Zhang, Shun-Xian, David Carmena, Cristina Ballesteros, et al.. (2021). Symptomatic and Asymptomatic Protist Infections in Hospital Inpatients in Southwestern China. Pathogens. 10(6). 684–684. 3 indexed citations
10.
Zhang, Shun-Xian, Yongkang Zhou, Xiuping Wu, et al.. (2020). <p>Molecular Epidemiology and Risk Factors of Blastocystis sp. Infections Among General Populations in Yunnan Province, Southwestern China</p>. Risk Management and Healthcare Policy. Volume 13. 1791–1801. 19 indexed citations
11.
Liu, Fangcen, Yanhong Chu, Qingqing Zhai, et al.. (2020). <p>MicroRNA-200c Nanoparticles Sensitized Gastric Cancer Cells to Radiotherapy by Regulating PD-L1 Expression and EMT</p>. Cancer Management and Research. Volume 12. 12215–12223. 19 indexed citations
12.
Liu, Qin, Dinghu Zhang, Hanqing Qian, et al.. (2020). <p>Superior Antitumor Efficacy of IFN-α2b-Incorporated Photo-Cross-Linked Hydrogels Combined with T Cell Transfer and Low-Dose Irradiation Against Gastric Cancer</p>. International Journal of Nanomedicine. Volume 15. 3669–3680. 25 indexed citations
13.
Zhang, Dinghu, Yanhong Chu, Hanqing Qian, et al.. (2020). <p>Antitumor Activity of Thermosensitive Hydrogels Packaging Gambogic Acid Nanoparticles and Tumor-Penetrating Peptide iRGD Against Gastric Cancer</p>. International Journal of Nanomedicine. Volume 15. 735–747. 40 indexed citations
14.
Ai, Lin, Jiaxu Chen, Yu-Chun Cai, et al.. (2019). Prevalence and risk factors of Fascioliasis in China. Acta Tropica. 196. 180–188. 7 indexed citations
15.
Chu, Yanhong, Qin Liu, Jia Wei, & Baorui Liu. (2018). Personalized cancer neoantigen vaccines come of age. Theranostics. 8(15). 4238–4246. 50 indexed citations
16.
17.
Zou, Bin, et al.. (2017). Immobilization of Lipase by Ionic Liquid-Modified Mesoporous SiO2 Adsorption and Calcium Alginate-Embedding Method. Applied Biochemistry and Biotechnology. 185(3). 606–618. 16 indexed citations
18.
Chen, Xiang, Chaowen Shi, Weilin Liu, et al.. (2017). The role of miR-497-5p in myofibroblast differentiation of LR-MSCs and pulmonary fibrogenesis. Scientific Reports. 7(1). 40958–40958. 41 indexed citations
19.
Cai, Yu-Chun, Junfang Xu, Peter Steinmann, et al.. (2014). Field comparison of circulating antibody assays versus circulating antigen assays for the detection of schistosomiasis japonica in endemic areas of China. Parasites & Vectors. 7(1). 138–138. 33 indexed citations
20.
Chu, Yanhong, et al.. (2005). [Study on the peaks linked to the crystalline of L-LA with variable temperature FTIR spectra method].. PubMed. 25(3). 384–6. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026